TDLAF

 
Common Stock International Reporting
OTCQB
Contact Info
  • Level 18, 101 Collins Street
  • Melbourne, VIC 3000
  • Australia

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Dec 31, 2016 Annual Report
CIK 0000943502
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: Australia
Year of Inc. 1989
Employees Not Available
Company Officers/Contacts
Justyn Stedwell Secretary
Company Directors
Jitto Arulampalam Chairman
Hongjen Chang
Service Providers
Accounting/Auditing Firm
BDO Audit Pty Ltd
38 Station St
Adelaide, VIC, 5000
Australia
 
Securities Counsel
Fleur Lankesheer
2806 Ipswich Road,
Darra, Brisbane, QL, 4076
Australia
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Progen Pharmaceuticals Ltd. until 11-2016
  • Formerly=Progen Industries Ltd. until 5-07
TDLAF Security Details
Share Structure
Market Value1 $3,720,702 a/o Oct 19, 2017
Authorized Shares 60,545,131 a/o Dec 16, 2014
Outstanding Shares 55,285,315 a/o Dec 16, 2014
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Computershare
Shareholders
Shareholders of Record 5 a/o Dec 27, 2010
Non US Stock Exchange Listing
TDL - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 0 (-100%)
Jan 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security